Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in NVCR — NovoCure Ltd

CIK 1692234 Seattle, WA
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,765,114
+$1,172,649 QoQ
Shares Held
182,516
+24.9% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,038,978,428 across 88 Medical Devices names. NVCR ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 2,288,745 $207,039,863
2 MDT
Medtronic plc
 1,750,957 $136,977,358
3 SYK
Stryker Corp
 420,962 $132,535,668
4 ABT
Abbott Laboratories
 1,380,872 $125,300,317
5 BSX
Boston Scientific Corp
 2,895,696 $123,588,298
6 DXCM
Dexcom Inc
 973,800 $65,585,423
7 GEHC
GE HealthCare Technologies Inc.
 662,351 $42,397,082
8 PODD
Insulet Corp
 163,842 $24,944,937

All Filings in NVCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,765,114 182,516
2026-03-31 $1,592,465 146,098
2025-12-31 $2,006,719 155,199
2025-09-30 $529,588 40,990
2025-06-30 $61,426 3,451
2025-03-31 $116,345 6,529
2024-12-31 $34,508 1,158
2024-09-30 $51,469 3,293
2024-06-30 $198,260 11,574
2024-03-31 $2,036,305 130,282
2023-12-31 $560,036 37,511
2023-09-30 $1,070,015 66,255
2023-06-30 $3,264,597 78,665
2023-03-31 $5,184,547 86,208
2022-12-31 $2,839,744 38,715
2022-09-30 $2,908,589 38,281
2022-06-30 $2,554,958 36,762
2022-03-31 $3,037,610 36,664
2021-12-31 $2,706,707 36,051
2021-09-30 $4,127,170 35,527
2021-06-30 $7,719,556 34,801
2021-03-31 $11,079,192 83,819
2020-12-31 $12,533,802 72,433
2020-09-30 $4,124,590 37,055
2020-06-30 $3,852,779 64,971
2020-03-31 $4,856,422 72,118